EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis

Ryo Morikawa, Toshimitsu Fujii, Akiko Tamura, Ami Kawamoto, Shuji Hibiya, Kento Takenaka, Hiromichi Shimizu, Yoshihito Kano, Mitsukuni Suenaga, Yasuo Hamamoto, Kazuo Ohtsuka, Ryuichi Okamoto

Digestion · 06.12.2025 · 1-10

DOI: 10.1159/000549888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestion, online erschienen am 06.12.2025. Verfasst von Ryo Morikawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Immune-related adverse events (irAEs), which occur due to loss of immune tolerance, represent a significant challenge when using immune checkpoint inhibitors (ICIs). As the indications for ICIs continue to expand, the incidence of irAEs has been increasing. Immune-mediated diarrhea and colitis (IMDC) is one of the most frequent irAEs. Although important for the management of IMDCs, colonoscopy is highly invasive for patients with cancer, and development of noninvasive alternatives is needed.

Methods

We prospectively enrolled patients diagnosed with IMDC between May 2019 and May 2025, and a total of 34 patients were included in the final analysis. Blood and stool samples were collected, and biomarker levels were measured. Endoscopic activity was defined as a Mayo Endoscopic Subscore of ≥2, as evaluated during colonoscopy. The relationship of each biomarker with endoscopic activity was examined using Spearman’s rank correlation and receiver operating characteristic curve analysis.

Results

Fecal calprotectin (FC), fecal lactoferrin (FL), and fecal immunochemical test (FIT) were significantly correlated with the Mayo Endoscopic Subscore, with correlation coefficients of 0.50, 0.51, and 0.74, respectively. These biomarkers effectively detected endoscopic activity, with high area under the curve values of 0.79, 0.81, and 0.94, respectively. Furthermore, certain combinations of fecal biomarkers enhanced accuracy, as demonstrated by FC (+) or FIT (+), which achieved a sensitivity of 95.5% and a specificity of 75.0%.

Conclusion

Fecal biomarkers were correlated with endoscopic activity and effectively identified patients with endoscopically active IMDC. Our findings suggest that these biomarkers may be valuable tools for the diagnosis and assessment of treatment response in IMDC.

Schlagwörter

Stichwörter der Autor:innen

Fecal calprotectinFecal immunochemical testFecal lactoferrinImmune checkpoint inhibitorImmune-related diarrhea and colitis

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan, tfujii.gast@tmd.ac.jp.
  • Department of Medical Oncology, Institute of Science Tokyo, Tokyo, Japan.

Zitieren

APA

Morikawa, R., Fujii, T., Tamura, A., Kawamoto, A., Hibiya, S., Takenaka, K., Shimizu, H., Kano, Y., Suenaga, M., Hamamoto, Y., Ohtsuka, K., & Okamoto, R. (2025). Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis. Digestion, 1-10. https://doi.org/10.1159/000549888

Vancouver

Morikawa R, Fujii T, Tamura A, Kawamoto A, Hibiya S, Takenaka K, et al. Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis. Digestion. 2025:1-10. doi:10.1159/000549888

BibTeX
@article{Morikawa2025,
  author = {Morikawa, Ryo and Fujii, Toshimitsu and Tamura, Akiko and Kawamoto, Ami and Hibiya, Shuji and Takenaka, Kento and Shimizu, Hiromichi and Kano, Yoshihito and Suenaga, Mitsukuni and Hamamoto, Yasuo and Ohtsuka, Kazuo and Okamoto, Ryuichi},
  title = {Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis},
  journal = {Digestion},
  year = {2025},
  pages = {1--10},
  doi = {10.1159/000549888}
}
Kostenlos starten →